Related Experiment Videos

Invasive aspergillosis complicating induction chemotherapy of childhood leukaemia

T Bömelburg1, N Roos, H J von Lengerke

  • 1Kinderklinik, Universität Münster, Federal Republic of Germany.

Insights

Invasive aspergillosis can rapidly affect children with acute leukaemia soon after starting chemotherapy. Early detection is crucial, as infections can manifest in lungs or the abdomen, potentially leading to disseminated disease.

Area of Science:

  • Pediatric Oncology
  • Infectious Diseases
  • Mycology

Background:

  • Acute leukaemia treatment often involves intensive polychemotherapy, leading to profound immunosuppression.
  • Invasive fungal infections, particularly invasive aspergillosis, are a significant cause of morbidity and mortality in immunocompromised pediatric patients.
  • The early phase of induction chemotherapy poses a critical window for opportunistic infections.

Observation:

  • Two pediatric patients with acute leukaemia developed invasive aspergillosis within two weeks of initiating polychemotherapy.
  • One patient presented with pulmonary aspergillosis (aspergilloma) following upper lobe infiltration.
  • The second patient developed caecal aspergillosis, initially mimicking appendicitis, which progressed to disseminated disease.

Findings:

  • Histologically confirmed invasive aspergillosis occurred rapidly after chemotherapy initiation in both cases.
  • Pulmonary and gastrointestinal tracts are potential sites for early invasive aspergillosis in this population.
  • Despite antifungal therapy, disseminated aspergillosis led to a fatal outcome in one patient.

Implications:

  • Clinicians must maintain a high index of suspicion for invasive aspergillosis in pediatric leukaemia patients presenting with new symptoms shortly after chemotherapy initiation.
  • Diagnostic vigilance is required to identify aspergillosis in atypical presentations, such as abdominal symptoms mimicking appendicitis.
  • Prompt diagnosis and management are critical to improve outcomes for invasive aspergillosis in pediatric oncology.

Related Concept Videos